Galmed Pharmaceuticals Ltd. Ordinary Shares — Institutional Ownership
Which tracked institutions hold GLMD, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
4
Funds holding
$57
Total value held
Buying
2 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $31 | 56 | -101 | -64.33% |
| 2 | Wells Fargo & Company/Mn | $24 | 43 | — | Held |
| 3 | Ubs Group Ag | $2 | 3 | +3 | NEW BUY |
| 4 | Royal Bank Of Canada | $0 | 550 | +550 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.